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Background: Women who deliver preterm infants are at a much greater risk for repeating a preterm birth (PTB),
compared to women without a history of PTB. However, little is known about the prevalence of the risk factors
which account for this markedly increased risk. Moreover, little or nothing is known about the feasibility of providing
treatments and services to these women, outside of the context of prenatal care, during the inter-conception period,
which provides the best opportunity for successful risk-reduction interventions.
Methods: The Philadelphia Collaborative Preterm Prevention Project (PCPPP), a large randomized control trial designed
to identify and reduce six major risk factors for a repeat preterm birth among women immediately following the
delivering of a preterm infant. For the women assigned to the PCPPP treatment group, we calculated the prevalence
of the six risk factors in question, the percentages of women who agreed to receive high quality risk-appropriate
treatments or services, and the of rates of participation among those who were offered and eligible for these
treatments or services.
Results: Urogenital tract infections were identified in 57% of the women, while 59% were found to have periodontal
disease. More than 39% were active smokers, and 17% were assessed with clinical depression. Low literacy, and
housing instability were identified in, 22 and 83% of the study sample, respectively. Among women eligible for
intervention, the percentages who accepted and at least minimally participated in treatment ranged from a low of
28% for smoking, to a high of 85% for urogenital tract infection. Most PCPPP enrollees (57%) had three or more major
risk factors. Participation rates associated with the PCPPP treatments or services varied markedly, and were quite low
in some cases, despite considerable efforts to reduce the barriers to receiving care.
Conclusion: The efficacy of individual level risk-reduction efforts designed to prevent preterm/repeat preterm in
the pre- or inter-conception period may be limited if participation rates associated with interventions to reduce
major risk factors for PTB are low. Achieving adequate participation may require identifying, better understanding,
and eliminating barriers to access, beyond those associated with cost, transportation, childcare, and service
location or hours of operation.
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Approximately 65-75% of infant mortality in the U.S. is
related to preterm birth (PTB), and premature births
account for almost half of all chronic and severe morbidity
in young children [1,2]. Every year more than 450,000 ba-
bies in the U.S. are born prematurely (defined as less than
37 completed weeks of gestation), accounting for 11.6 per-
cent of all live birth deliveries. Consequently, PTB has
been the subject of a considerable amount of epidemio-
logical and medical research. Unfortunately, the causes
are still not well-understood, and thus the path to redu-
cing PTB remains somewhat elusive [2].
The strongest predictor of PTB is a previous PTB.
Women with a previous PTB are between 2 to 5-fold
greater risk for a second PTB, compared to women with
a previous full term delivery [3]. Moreover, the earlier
the gestational age of a PTB, the greater the risk for
a repeat PTB. As many as 50% of women with a prior his-
tory of PTB occurring at or before 32 weeks gestational
age (GA) have a subsequent PTB [3,4].
Past efforts to reduce PTB have been largely unsuc-
cessful, perhaps because such efforts target a single risk
factor, and the corresponding services or interventions
have been offered only during the course of pregnancy.
What may be needed, therefore, are more comprehen-
sive, long term interventions, beginning prior to concep-
tion and thus outside the context of traditional prenatal
care [2,5,6].
In light of the extremely high rate of repeat preterm
delivery, the most obvious target group for inter-concep-
tional risk reduction is women with a history of preterm
birth. Unfortunately, little is known about this manifestly
high risk group in terms of the degree of willingness or
ability to participate in appropriate interventions or
services in the postpartum or inter-conceptional period.
Presented here are the result of an analysis of data
from the Philadelphia Collaborative Preterm Prevention
Project (PCPPP), a large randomized control trial designed
to identify and reduce risk factors for repeat preterm births
among women who previously delivered moderately to
severely premature (<35 weeks gestation) infants. PCPPP
data were examined to determine both the prevalence of
the major risk factors for PTB among enrollees, the fre-
quency with which enrollees agreed to treatment, as well
as the actual participation rates pertaining to each of the
intervention arms of the study.
The Philadelphia collaborative preterm prevention project
The results from both epidemiological and biological
studies suggest that PTB may be a function of a more
generalized pro-inflammatory process that increases the
overall likelihood that some women will deliver prema-
turely [2,7-9]. Infections such as periodontal disease [10],
urogenital tract infections [7], bacterial vaginosis and othersexually transmitted diseases [11], and pneumonia and
influenza [2] are in fact associated with the increased risk
of PTB. For that reason the core PCPPP intervention
protocol focused on the social, behavioral and medical
factors that may contribute to an increased risk of PTB
through an inflammatory pathway or systemic inflam-
mation (SI) – specifically, smoking, depression, infectious
disease burden, periodontal disease and maternal stress. A
more detailed discussion of the justification for organizing
the intervention protocol of PCPPP around SI-related fac-
tors has been published elsewhere [12,13]. An explanation
of, and data pertaining to, the randomization process and
the overall recruitment and retention of the women who
enrolled in the PCPPP trial are also available in that publi-
cation. Systematic and continuous data collection and risk
assessment were an integral part of the PCPPP study
design with the objective of continuously identifying,
referring and providing treatment for all women with any
of the risk factors associated with SI noted above.
As described in more detail below, presence of the risk
factors was determined using widely accepted medical
procedures, or by way of standard social/behavioral as-
sessments, administered by appropriately trained, profes-
sional or licensed staff. In addition, a comprehensive set
of strategies were developed and implemented in order
to eliminate barriers to receiving treatment and services,
offered as a complement to intervention arms of the
PCPPP trial. These strategies were in fact intended to
maximize participation and included, but were not
necessarily limited to: providing treatment or services
completely cost-free; reimbursement for any costs related
to transportation to and from clinical sites, including use
of tokens and cab vouchers, or door-to-door, pick-up and
drop-off car service provided by staff; free childcare; flex-
ible clinical hours, including evening and weekend hours;
and in home-visits when appropriate. In addition, PCPPP
staff routinely followed-up with women regarding missed
appointments. Underlying these measures was recognition
of high thresholds of participation as a prerequisite for
effective risk reduction, and for our ability to evaluate the
effectiveness of the PCPPP interventions designed to
reduce repeat preterm birth rates
Methods
Data
All women who were identified to us by the hospital, or
by the Pennsylvania Department of Health using their
electronic birth record reporting system, as having deliv-
ered at 35 weeks gestation or less were approached by
PCPPP staff for permission and written consent to enroll
in the study. From September of 2004 through August of
2008 the PCPPP team recruited from twelve Philadelphia
hospitals providing 70% of the obstetric services in the
region. Eligibility for enrollment was defined as: 1) delivery
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Spanish speaking; 3) Philadelphia area residency; and 4)
not receiving operative sterilization before discharge from
the hospital. A total of 1,450 women met the eligibility
criteria for PCPPP and were approached for enrollment.
Of those 324 refused and 1,126 women agreed to enroll in
the PCPPP trial. There were no significant sociodemo-
graphic differences between those who agreed and those
who refused to enroll [12]. Of those who agreed to enroll
565 were randomized into the intervention group and 561
into the control group. All women who enrolled were
asked to attend study visits and repeatedly assessed at 1, 6,
12, 18 and 24 months postpartum. Women randomized
into the treatment group were regularly assessed for the
presence of the pre-specified risk factors and invited to
avail themselves of the state of the art treatment and
services offered as part of the PCPPP protocol, which
are described in detail below. Consequently, in all cases,
and for the purposes of the analyses described below, the
“prevalence” of a risk factor refers to period prevalence.
In other words, if at any time during any study visit an
enrollee was assessed as having a particular risk factor,
that enrollee was classified and counted as being at-risk
for the risk factor in question. Similarly, treatments and
services were offered based on need; specifically, inter-
ventions were offered based on assessments made over
the entire course of the study visit schedule. Thus enrollees
were continuously assessed and offered risk-appropriate
treatments and services—initially when the risk factor was
first identified, if the risk factor persisted based on any sub-
sequent study visit, or if the risk factor re-appeared during
any subsequent study visit. Women who were random-
ized into the control group were administered identical
assessments as the intervention group, were informed
of the results, and were referred to appropriate med-
ical or social service providers in the community, if
available, but received none of the on-site, enhanced
services or treatments funded by the PCPPP. Ethical
approval to conduct the study was granted by the Insti-
tutional Review Board of Drexel University, Philadelphia
Department of public Health, and the University of
Pennsylvania.
A total of 471 women in the intervention group received
at least one complete follow-up clinical assessment, and it
is those women who comprise the analytical sample for
the findings presented here. Based on a preliminary ana-
lyses of survey data collected at the time of enrollment we
found that women assigned to the intervention group but
who were lost to follow up after enrollment (n = 94) were
not significantly or substantively different from the 471
women in the study sample, in terms of race/ethnicity,
income, age, education, insurance status, birth weight or
gestational age of the infant (Not shown; data provided
upon request).Study variables
Key variables used in the analysis included 1) the pres-
ence or prevalence of risk factors for PTB/repeat PTB
discussed above, which determined participant eligibility
for treatment; 2) rates of acceptance by participants for
risk-appropriate treatment; and 3) minimal participation
rates in the treatment protocols.
1. Determination of the presence/ prevalence of risk
factors.
A summary of the protocol used for determining the
presence of each risk factor and the corresponding
intervention is presented in Table 1. Briefly stated:
 Urogenital tract infections. Biological samples
were obtained by professional staff; presence
of infection was based on result of standard
laboratory testing. Medically appropriate
antibiotic treatment was offered to all women
who tested positive for infection.
 Periodontal disease. Periodontal assessment was
completed by a licensed dental hygienist using
the American Dental Association’s Periodontal
Screening and Recording (PSR) questionnaire
[14]. Women screening positive were sent to
DDM/periodontist for clinical confirmation of
periodontal disease and the development of a
treatment plan which included scaling, root
planing and/or extraction when appropriate.
 Smoking. Standard questionnaires administered
by trained staff; interventions included range of
acceptable treatments, including supportive
counseling, nicotine patch therapy or Wellbutrin,
or a combination of the above.
 Depression. Administration of the Center for
Epidemiologic Studies Depression Scale (CES-D),
a commonly used screening instrument for
depressive symptomatology with known reliability
and validity [15,16]. Women with CES-D scores
of 16 or greater were considered to have depressive
symptomatology and asked to complete the
The Structured Clinical Interview for DSM-IV
Dissociative Disorders (SCID), widely used in
research settings in order to diagnose depression
[17]. The SCID was administered by appropriately-
trained and licensed professional study personnel.
Those determined to have major depressive
disorder were offered cognitive behavioral
therapy (provided by a Masters prepared, licensed
social worker or licensed psychologist), or
psychopharmacology (provided by a staff
psychiatrist) – or both.
 Low literacy. A Standardized test, the Short
Test of Functional Health Literacy in Adults
(S-TOFHLA) or the Test of Adult Basic
Table 1 Definition of Risk factor identification, interventions, and participation
Risk factor/Intervention Definition of (Minimal) Participation/Strategies to
address potential barriers to participation
Infection Identification: Positive, based on standard medical diagnostics
for STD’s and urogenital tract infections, including Bacterial Vaginosis
(BV), Chlamydia, Trichomoniasis, Gonorrhea, yeast infection, excessive
bacteruria, and Syphilis. Tests were conducted at the centralized
clinical setting; all lab results were reviewed by the study-trained
laboratory coordinator.
Participation: Prescribed and provided (on site) standard
medical treatment for all infections. with confirmation by
direct observation that medication was taken
Treatment: Follow-up and standard medical treatment for all
conditions identified; supervised by the study medical team and
free of charge.
Strategies. No cost treatment, flexible clinical hours,
transportation to and from appointments, free childcare,
follow up by social workers
Periodontal
disease
Identification. Screened positive for clinical periodontal disease.
Assessment, including soft tissue exam for oral cancer, Plaque Scores,
Gingivitis Index Scores, Probing Pocket Depth, Bleeding Upon Probing,
Clinical Attachment Level, and cementoenamel junction. Initial
screening, was completed by the study registered dental hygienist and
the presence of periodontal diseases was confirmed by a licensed
periodontist.
Participation Attended at least one dental clinic
appointment for scaling, root planning or surgery
Treatment: Individually-tailored intervention including oral hygiene
education and comprehensive clinical treatment for all conditions identified.
Presence of periodontal disease was confirmed through x-ray and clinical
exam by a DDM. Treatment for periodontal disease was provided by or
under direct supervision of a periodontist/DDM, free of charge
Strategies: No cost treatment, flexible clinical hours,
transportation to and from appointments, free childcare.
appointment reminders. PCPPP staff was also available to
accompany women to dental visits when requested.
Smoking Identification. Reported smoking during pregnancy or postpartum
period based on standardized questionnaire administered by
study staff.
Participation: Attended at least one individualized or
group counseling session, and/or received nicotine
replacement therapy
Treatment: Referral and follow-up for smokers, who were offered
individually-tailored one-on-one cessation counseling and
pharmacotherapy, including standard nicotine replacement therapy,
and bupropion. One-on-one counseling was provided by certified
smoking cessation counselor; pharmacotherapy was provided and
prescribed by physician
Strategies: Free treatment, flexible hours, in home visits,
free transportation to and from any scheduled




Identification. Screening with Center for Epidemiological Studies
of Depression Scale (CES-D ≥16) followed by a diagnostic interview
with the Structured Clinical Interview for DSM Disorders (SCID) for
those with a positive screen. The SCID was administered by
appropriately trained study physician or social worker.
Participation: Attended at least one therapy session
and/or received medication for depression
Treatment: Participants who were diagnosed with current major
depressive disorder were offered medical treatments comprised
of cognitive behavioral therapy, antidepressant psychopharmacology,
following standardized protocols, or the combination of the two
treatments. Women who declined these therapies were offered
supportive counseling and problem solving training delivered by
clinical social workers in home visits.
Strategies: Free treatment, flexible hours, free
transportation to and from any scheduled appointment,
free childcare, appointment reminders, in home visits.
Low literacy Identification. Based on Short Test of Functional Health Literacy
in Adults (inadequate and marginal: English and Spanish), Test of
Adult Basic Education - Reading Locator (levels E&M; TABE)
administered by study staff.
Participation: Attended at least one, one-on-one or
classroom session to improve literacy
Treatment: An individually tailored learner-driven intervention model
was utilized using a contextual adult educational curriculum focused
on building skills for navigating hurdles to maternal-infant care and
family management/economics. Adult literacy skills were developed
through working individually with professional adult educators on
specific challenges faced by the participants and selected by them.
Strategies Free treatment, flexible hours, free
transportation to and from any scheduled appointment,
free childcare, appointment reminders
Housing Identification. Based on comprehensive assessment of housing status
and stability conducted by study staff. Those with problems indicating
imminent eviction, in unsafe or unhealthy living environments were
considered as
Participation: Received any form of financial, or relocation
assistance in order to improve/stabilize housing situation,
or mediation services to resolve landlord/tenant dispute
Instability Treatment: Housing assistance, when appropriate, was provided
in the form of cash grants for down payments or back rent,
relocation services, or resolution of landlord/renter disputes,
provided under the direction of a MSW, with experience in
resolving housing-related issues
Strategies. Flexible hours, free transportation to
and from any scheduled appointment, free childcare,
appointment reminders
Webb et al. BMC Pregnancy and Childbirth 2014, 14:368 Page 4 of 10
http://www.biomedcentral.com/1471-2393/14/368
Webb et al. BMC Pregnancy and Childbirth 2014, 14:368 Page 5 of 10
http://www.biomedcentral.com/1471-2393/14/368Education (TABE), commonly used instruments
for assessing health literacy [18]. Both the
S-TOFHLA and the TABE were administered by
licensed social workers. The interventions for
those determined to have low health literacy were
individually-tailored and provided by professional
adult educators.
 Housing instability. Completion of a
comprehensive assessment of living
arrangements, affordability, safety and threat or
likelihood of eviction based on face to face
interviews. The interventions for housing
instability were individually-tailored, contingent
on need, and provided by a licensed social worker
experienced with resolving housing crises
commonly occurring in lower income populations.
2. Acceptance rates. Participants in the intervention
group were classified as having accepted treatment
if, after being informed of their conditions, they
consented in writing to the respective treatment
options described above.
3. Minimal participation rates. A summary of how
minimal participation was defined for this analysis is
provided in last column of Table 1. In the majority
of cases minimal participation was defined as at least
one appropriate ‘follow-through’ by those
participants who were identified with a risk factor,
and therefore eligible for services or treatment. For
periodontal disease and depression participation was
defined as having made at least clinic visit for
treatment. For smoking participation was defined as
having attended at least one group or individual
counseling session. For low literacy a women was
considered to have participated if she attended at
least one session designed to improve reading skills.
In the case of urogenital infections an enrollee
was classified as participating if she accepted the
appropriate medication, which was provided on site
and confirmed as taken appropriately through direct
observation. For housing instability enrollees were
classified as having participated if they accepted and
received any tangible assistance to improve or stabilize
their physical housing condition, including money to
pay overdue rent or utility bills, relocation services, or
mediation to resolve a landlord/tenant dispute.
In brief, the consistent theme underlying the
definition of “participation” was any confirmed use
of treatment or risk-reduction services by eligible
women; participation was, therefore, always defined
minimally. The terms ‘participation’ and ‘minimum
participation’ are used interchangeably here.
The strategies used to address potential barriers to
access to treatments or services are also presented
in Table 1.Statistical analyses
The sociodemographic characteristics, including race/eth-
nicity, education, income, as well as nativity, marital and
insurance status were collected at the time of by means of
face-to-face surveys administered at the time of enroll-
ment. Simple frequency distribution procedures were used
to describe the study sample, and calculate eligibility, ac-
ceptance and participation rates.
Previous research has shown that minority and/or low
socioeconomic status are associated with skepticism about,
and unwillingness to participate in, medical research, in-
cluding randomized control trials [19]. These same factors
are also known to impede a woman’s ability to avail herself
of health care and related services [20]. In order to deter-
mine the extent to which these factors were influencing
participation rates for women in the study sample, we
explored differences in risk factor prevalence, accept-
ance rates, and participation rates according to both
race/ethnicity and insurance status (private vs. Medicaid
or uninsured). A preliminary analysis of the data revealed
that the pattern of relationships between prevalence,
acceptance and participation rates on the one hand, and
education and household income on the other, was very
similar to that for insurance status. Consequently, for the
sake of brevity and for purposes of illustration, only data
pertaining to insurance status are presented here. Cross-
tabulations were used to examine these differences, and
chi-square values were calculated and used to identify any
statistically significant relationships. (The Fisher’s Exact
Test was substituted for chi-square if the expected value
in any cell was less than 5). In cases where both insurance
status and race/ethnicity were significantly correlated with
the dependent variables (prevalence, acceptance, and par-
ticipation) logistic regression analysis was conducted to
determine if the associations were independently related
to the dependent variables. The analysis was conducted
using standard statistical programming software available
in STATA 12.1 [21].
Results
The sociodemographic and other characteristics of the
PCPPP intervention group are shown in Table 2. Of the
471 women who were randomized into the intervention
group and had at least one post-delivery clinical assess-
ment, 93 percent were US born. In terms of race/ethnic
composition, 72 percent were non-Hispanic Black, 10
percent were Non-Hispanic White, while the remaining
18 percent identified themselves as Hispanic or of some
other race/ethnic group. More than 30% had not fin-
ished high school or completed a GED at the time of the
index delivery. More than one-half (57.5%) reported
household incomes of less than $30,000 per year, while
about 70 percent were on Medicaid or were uninsured
at the time of enrollment. The average age of mother at
Table 2 Description of the study sample
PCPPP Intervention Group: with at least one post-delivery clinical
assessment
All Women N = 471 (100.0%)
US born 440 (92.6)
Race/Ethnicity






College or more 133 (28.0)
Married 84 (17.7)





Private insurance 143 (30.3)
Medicaid 317 (66.9)
Uninsured 14 (3.0)
Age mean (sd) 25.6 (6.6)
GA mean (sd) 30.1 (4.0)
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25.6 years, while the average gestational age of the index
preterm birth was 30.2 weeks.
As Figure 1 shows, 6 percent of women had no iden-
tified risk factors, 14 percent had only one risk factor,
22 percent had two risk factors, 31.4 percent had three
risk factors and 25.9 percent had 4 or more major risk
factors for a PTB. Prevalence rates for each of the majorFigure 1 Distribution of risk factors for PCPPP intervention
group.risk factors assessed are presented in Table 3. Of the
women in the study sample 57.3 percent were diagnosed
with urogenital tract infection, and 58.6 percent with
periodontal disease. About 39 percent of women in the
intervention group were identified as cigarette smokers.
Just over 60 percent of the women had CES-D scores
of >16; of these 81 or 17.2 percent were determined
to be clinically depressed. A total of 106 or 22.5 percent of
enrollees were determined to be reading at low levels of
literacy. The assessment of housing conditions revealed
that 392 of the women, or 83.2 percent, were living in an
unstable housing situation.
Intervention/treatment acceptance rates are presented
in column 2 of Table 3. In all cases, the majority of
women was receptive and thus agreed to the respective
treatment protocols. Specifically, of those diagnosed with
a urogenital tract infection, 90.2% stated they were will-
ing to accept treatment and took the medication in the
presence of PCPPP staff. Acceptance rates for periodon-
tal disease, clinical depression, literacy and housing were
88.6%, 95.1%, 68.9%, and 91.1%, respectively. In compa-
rison, among those who were identified as smokers and
therefore eligible for treatment, only 57.3% stated they
were willing to accept treatment.
Participation rates, as percentage of women eligible for
treatment varied considerably across the intervention
arms of the study (Table 3: column 3). Exactly 85.0 per-
cent of women diagnosed with urogenital tract infection
met the definition of minimal participation described
earlier, compared to 48.7 percent for periodontal disease.
Among identified smokers, 28.1 percent participated by
receiving some form of intervention designed to help
women reduce or quit smoking. For the women with
depressive symptomatology and who were subsequently
determined to be clinically depressed the corresponding
participation rate was 74.1 percent. The rate of partici-
pation for women identified with low literacy levels was
40.2 percent. Finally, among those women determined
to be living in an unstable housing conditions, 66.1 per-
cent participated by receiving some form of housing
assistance.
The results of our analysis of differences in preva-
lence, acceptance and participation rates according to
race/ethnicity and insurance status are presented in
Table 4. Black (63.4%) and Hispanic women (49.4%) were
far more likely than White women (28.9%) to have been
diagnosed with a urogenital tract infection, and both Black
and Hispanic women had much higher rates of periodon-
tal disease than white women (61.5% and 69.0% vs. 23.8%,
respectively). The assessments of health literacy revealed
proportionally more black (24.0%) and Hispanic (24.7%)
compared to white (8.7%) women with low literacy
levels. Similarly, proportionately more black (85.8%) and
Hispanic (84.4%) compared to white (58.7%) women were
Table 3 Risk factor prevalence, acceptance rates and rates of minimal participation in PCPPP treatment protocols1
Prevalence/Eligible (a) Acceptance rate (b)2 Participation rate3
N (%) N (% of Eligibles) N (% of Eligibles)
Intervention/Treatment
Urogenital tract infection 266 (57.3) 240 (90.2) 226 (85.0)
Periodontal disease 261 (58.5) 232 (88.8) 127 (48.7)
Smoking 185 (39.3) 106 (57.3) 52 (28.1)
Clinical depression 81 (17.2) 77 (95.1) 60 (74.1)
Low literacy 106 (22.5) 73 (68.9) 43(40.2)
Housing instability 392 (83.2) 357 (91.1) 259 (66.1)
1The number of women assessed (the denominator for prevalence) in all cases except for urogenital track infection and periodontal disease was 471. For
periodontal disease 446 women were assessed by the dental hygienist; 25 women could not be assessed for periodontal disease because the hygienist
experienced a temporary illness during the course of the study and was therefore unavailable at the time their clinic visit occurred. These 25 women were
subsequently lost to follow-up. For urogenital tract infection 464 women were assessed/swabbed for infections; over the course of the study a total of 7 women
had to leave the clinic before they could be tested for infections and were subsequently lost to follow-up.
2A women was classified as having accepted if she was identified as having a risk factor and agreed to receive the risk-appropriate treatment or service as defined
in Table 1.
3See last column of Table 1 for explanation of how “participation” was defined.
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on Medicaid or without insurance were more likely than
women with private insurance to have been diagnosed
with depression (20.1 vs. 20.5%), as having low health
literacy (26.2 vs. 14.1%), and as living in unstable
housing conditions (88.1 vs. 71.8%). Where prevalence
was significantly different according to both race/ethnicity
and insurance status (periodontal disease, literacy, and
housing conditions) the results of multiple logistic regres-
sion analysis indicated that the differences by race/
ethnicity were independent of those for insurance sta-
tus, and vice versa (data not shown, but available
upon request).
There were fewer instances where race/ethnicity and/
or insurance status were significantly associated with
rates of acceptance, with the general trend toward more
willingness to accept treatment for minority and Medic-
aid or uninsured women. Specifically, Black (91.9%) and
Hispanic (83.7%) women who were eligible for periodon-
tal treatment were more likely to accept treatment than
were White women (40.0%), while uninsured women or
women on Medicaid were more likely than women with
private insurance to accept the intervention for low liter-
acy (74.4 vs. 45.0%), and more likely to accept help with
housing problems (93.8 vs. 83.3%). Notably, as shown in
column 3 of Table 4, there were no differences according
to either race/ethnicity or health insurance status in terms
of the rates of participation (among those who accepted
treatment) for any of the treatment arms of the study, a
finding which we discuss in more detail below.
Discussion
The main purpose of the PCPPP trial was to determine
if a set of systematic, coordinated, evidenced-based risk-
reduction strategies implemented during the inter-
conception period would reduce the risk of a subsequentPTB. We are unaware of any similar large scale RCT
attempting to mitigate multiple known risk factors for
repeat PTB, in a cohort of women in the immediate
postpartum period following a premature delivery.
The findings presented here document the prevalence
of the risk factors in the study cohort, the willingness of
PCPPP enrollees to agree to receive treatment, and the
extent to which women participated in the medical and
other services offered as part of the PCPPP trial. As noted
earlier, participation rates were calculated based on the
lowest possible yet reasonable thresholds for classifying an
enrollee as having ‘participated’. In addition, the PCPPP
trial was designed to incorporate every reasonable effort
to eliminate, or at least minimize all known barriers to
accessing treatment or services.
Not surprisingly, given that the sample consisted of
women who had just delivered prematurely, the preva-
lence of the risk factors in the study sample appear to be
high when compared to available data for similar socio-
demographic populations. Recent data available from the
Centers for Disease Control (CDC) , for example, revealed
that 24.7 percent of adults 30 to 34 years of age had mild
to severe periodontal disease, and that rates increased
markedly with age for both men and women [22]. The
presence of periodontal disease in the CDC study was
established according to the CDC/American Academy of
Periodontology definitions, which are not directly compar-
able to ours. However, using a full-mouth examination
and clinical confirmation by a periodontist we found that
58.5 percent of the PCPPP intervention group had moder-
ate to severe periodontal disease. Pocket depth is generally
considered an important marker for periodontal disease
and all women identified as having periodontal disease in
the PCPPP trial had at least one site with pocket depth
≥4 mm. By comparison, the detailed data from the above-
mentioned CDC study showed that 29.6 percent of
Table 4 Prevalence, acceptance rates and rates of participation: by race/ethnicity and insurance status1
Prevalence/Eligible Accepted2 treatment1 Participated3 (as % of Eligibles)
N (%) N (%) N (%)
Infection White 13 (28.9)*** 11 (84.6) 10 (76.9)
Race/Ethnicity1Black 210 (63.4) 189 (90.0) 178 (84.8)
Hispanic 38 (49.4) 36 (94.7) 34 (89.5)
Private 72 (51.8) 64 (88.9) 59 (81.9)
Insurance Status
MA/Uninsured 194 (59.9) 176 (90.7) 167 (86.1)
Periodontal disease White 10 (23.8)*** 4 (40.0)*** 2 (20.0)
Black 198 (61.5) 183 (91.9) 102 (51.5)
Hispanic 49 (69.0) 41 (83.7) 21 (42.9)
Private 71 (51.8) 59 (83.1) 33 (46.5)
MA/Uninsured 189 (61.4) 173 (91.1) 94 (49.7)
Smoking status White 20 (43.5) 10 (50.0) 5 (25.0)
Black 132 (39.3) 75 (56.8) 37 (28.0)
Hispanic 32 (41.6) 20 (62.5) 9 (28.1)
Private 34 (23.9)*** 18 (52.9) 12 (35.3)
MA/Uninsured 151 (46.2) 88 (58.3) 40 (26.5)
Clinical depression White 7 (15.2) 6 (85.7) 5 (71.4)
Black 53 (15.7) 50 (94.3) 40 (75.5)
Hispanic 19 (24.7) 19 (100) 13 (68.4)
Private 15 (10.5)** 14 (93.3) 12 (80.0)
MA/Uninsured 66 (20.1) 63 (95.5) 48 (72.7)
Housing instability White 27 (58.7)*** 22 (81.5) 15 (55.6)
Black 289 (85.8) 265 (91.7) 192 (66.4)
Hispanic 65 (84.4) 61 (93.9) 44 (67.7)
Private 102 (71.8)*** 85 (83.3)** 62 (60.8)
MA/Uninsured 289 (88.1) 271 (93.8) 197 (68.2)
Low literacy White 4 (8.7) 1 (25.0) 1 (25.0)
Black 81 (24.0) 57 (70.4) 31 (37.8)
Hispanic 19 (24.7) 13 (68.4) 10 (52.6)
Private 20 (14.1)** 9 (45.0)* 7 (35.0)
MA/Uninsured 86 (26.2) 64 (74.4) 36 (41.4)
1There were 13 women who identified themselves as being something other than white, black or Hispanic; because of the small number they were not included
in the figures for Race/Ethnicity shown here.
2A women was classified as having accepted if she was identified as having a risk factor and agreed to receive the risk-appropriate treatment or service as defined
in Table 1.
3See last column of Table 1 for explanation of how “participation” was defined.
***p < .0001; **p < .01; *p < .05.
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depth >4 mm and that rates increased markedly with
age. This is consistent with the conclusion that PCPPP
women had a prevalence of periodontal disease consider-
ably higher than that in the general population of women
of similar age, especially in light of the fact that the average
age of the PCPPP intervention group was only 25.6.
Data from the recent National Health Interview Survey
reveal that about 21 percent of women 18–44 years age
are current smokers [23], compared to almost 40 percent
reported here. With respect to the prevalence ofdepression, reports tend to vary considerably depending
on the screening instrument used, the cut-offs used to de-
fine depression and depression severity, or whether point
or period prevalence rates are in question, among other
things. Hence the precise ‘true’ prevalence of depression
among postpartum women or women of childbearing age
is unclear. A systematic review of the literature by Gavin
and colleagues revealed that, approximately 19 percent of
new mothers suffer from some form of depression at some
point during the first three months following delivery, and
as many as 7 percent have been diagnosed as having
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a total of 471 women in the intervention group were
screened for depressive symptomatology during the first
3 months postpartum; of those 237 or 29 percent were
identified as being “possibly depressed” according to
the Center for Epidemiological Studies of Depression
Scale (CES-D). Subsequent evaluation of the “possibly de-
pressed” group using the SCID revealed that 16 percent of
the intervention group was clinically depressed, more than
twice the equivalent period prevalence rate reported by
Gavin and colleagues.
Urogenital tract infections screened for in the PCPPP
study intervention included the more commonly reported
conditions of bacterial vaginosis, chlamydia, and gonor-
rhea. The prevalence of these conditions in the study
sample was 49, 10, and 1.7 percent, respectively, com-
pared to 19, 2.2, and 0.24 percent reported elsewhere
for young adult women or women of childbearing age in
general [25-27].
In addition to the prevalence of the risk factors
targeted for intervention in the PCPPP trial we also
documented the rate at which eligible women were
willing to participate in the respective interventions.
With the exception of the smoking intervention the over-
whelming majority of women identified with other risk
factors expressed the willingness to receive the appro-
priate treatment or services. The analysis of participation
patterns revealed that eligible women availed themselves
of the various PCPPP treatments and services in widely
varying degrees, ranging from a high of 85 percent
(for infection) to a low of 28 percent (for smoking).
Approximately 2 out of every 5 women identified with
low literacy levels eventually received any related services,
and fewer than half of the women with confirmed peri-
odontal disease ever had any follow-up treatments. Again,
in each case, every reasonable effort was made to remove
or mitigate what are the most often-cited ‘barriers’ to
receiving health care and related services – including
full reimbursement for costs and personalized accommo-
dations related to transportation to and from clinical sites,
free childcare, flexible and convenient clinical hours, and
even home visits when necessary.
Not surprisingly, in most cases, the prevalence of risk
factors was significantly higher for minority as compared
to white women, and for low income women, as measured
by insurance status. Black women enrolled in the study,
for example, were more than two times more likely than
white women to have been diagnosed with a urogenital
tract infection and more than two and one-half times
more likely to have been diagnosed with periodontal dis-
ease. In addition, both Black and Hispanic women were
significantly more likely than white women to have repor-
ted housing instability, and were also significantly more
likely to have elevated rates of low literacy.There was no evidence to suggest that minority and
low income women were either more reluctant to accept
or able to take advantage of medical treatments or services
offered as part of the PCPPP trial. Where rates of accept-
ance differed to any degree they tended to be higher among
minority as opposed to white women (in the case of peri-
odontal disease and low literacy) or higher among women
who were uninsured or on Medicaid, as compared to pri-
vately insured women (in the case of housing instability).
Moreover, there were no significant differences in participa-
tion rates associated with either race/ethnicity or insurance
status, pertaining to any of the treatments or services
offered as a part of the PCPPP interventions. The absence
of any meaningful relationship between these socio-
economic factors and participation rates for the PCPPP
trial suggests that the strategies used to make treatments
and services as accessible as possible efforts were fairly
successful.
The findings presented here also highlight the possi-
bility of widely varying participation rates pertaining to
interventions or programs offering multiple health and
health-related treatments and services to women in the
pre- or inter-conception period. Undoubtedly, participa-
tion will vary according to the perception of the benefits
to those who enroll. Many other factors, however, will
likely influence participation rates across ‘types’ of service
or treatments. Ensuring that high-risk women will be able
or willing to avail themselves of multiple appropriate treat-
ments or services during the pre- or inter-conceptional
period is increasingly being recognized as necessary to re-
duce the risk of PTB, since the underlying cause may be
the cumulative effect of exposures and conditions which
predate pregnancy, and may not be detectable or ade-
quately addressed within the gestational period [2,6,7,28].
Unfortunately, the forces that motivate, enable, or inhibit
women from accessing needed services outside the con-
text of prenatal care, in the pre- or inter-conceptional
period, are likely to be quite complex and are by no
means fully understood. Successfully identifying the ap-
propriate strategies for increasing access to and use of
risk-reduction strategies and services may well require
innovative and multi-level methodologies that match the
complex nature of the problem.
Conclusions
In summary, further research in this area appears war-
ranted. We believe that we systematically and thoroughly
addressed the well known and widely cited barriers asso-
ciated with women’s access to and use of health-related
services. Efforts to maximize participation of PCPPP en-
rollees were quite extensive, conducted as part of a fully-
funded, large-scale randomized control trial to reduce
repeat preterm birth. Nonetheless, participation rates var-
ied and in some cases were quite low, even when defined
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http://www.biomedcentral.com/1471-2393/14/368in fairly minimal terms. This raises not only an important
question about what more needs to be done in order
to successfully deliver multiple high-quality risk-reduction
interventions and services to high risk women, but also
the relative costs and benefits of doing so. The more
the chances of successfully reducing preterm birth
rates hinge and are placed on interventions targeting
high risk women prior to conception, the more im-
portant an adequate understanding of how to success-
fully reach such women with appropriate services and
treatment becomes.
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